-
2201
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
Published 2025-01-01“…Results A total of five RCTs and four PSM observational studies involving 26,753 patients (mean [SD] age, 62.9 [10.5] years; 6,406 female [24.0%]; 16,369 T2DM [61.2%]; 13,933 HF [52.1%]) were included. …”
Get full text
Article -
2202
-
2203
New role of platelets in schizophrenia: predicting drug response
Published 2024-04-01Get full text
Article -
2204
Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial
Published 2025-01-01“…Safety was evaluated by analysing adverse events.Results A total of 107 patients with active r-axSpA were randomised (jaktinib 75 mg two times per day, n=35; jaktinib 100 mg two times per day, n=36; placebo, n=36). …”
Get full text
Article -
2205
-
2206
-
2207
Mapping outcomes for recovery of consciousness in studies from 1986 to 2020: a scoping review protocol
Published 2022-06-01Get full text
Article -
2208
-
2209
Estudio genético en adultos con glomeruloesclerosis focal y segmentaria
Published 2025-02-01Get full text
Article -
2210
Comparative Proteomic Analysis of Visceral Adipose Tissue in Morbidly Obese and Normal Weight Chinese Women
Published 2019-01-01Get full text
Article -
2211
-
2212
-
2213
Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
Published 2023-03-01“…In this study we compared methylation levels of 27,578 CpG sites between paired samples of the tumor and surrounding liver tissues with various degrees of damage (fibrosis, cirrhosis) in HCV-induced hepatocellular carcinoma (HCC) patients, as well as between tumor and normal tissue in non-viral HCC patients, using GSE73003 and GSE37988 data from GEODataSets (https://www.ncbi.nlm.nih.gov/). …”
Get full text
Article -
2214
-
2215
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Published 2024-01-01“…To characterize the clinical features of long-term responders, we combined data from our prospective trial with a retrospective cohort of patients with anal cancer treated with anti-PD-1 immunotherapy (n=18).Results In the phase II study, the ORR to pembrolizumab monotherapy was 9.4% and the median progression-free survival was 2.2 months. …”
Get full text
Article -
2216
-
2217
-
2218
Feasibility and usefulness of Gini coefficients of primary care visits as a measure of service inequality: preliminary findings from a cross-sectional study using region-wide elect...
Published 2025-02-01“…While the observed GPVs for all causes witnessed: great inter-region variations, with the highest GPV being 4.38 times the lowest; a general decreasing trend over the 9-quarter period, being reduced by 18.48% on average; and atypical J-shaped trajectories along age groups for both sexes. …”
Get full text
Article -
2219
-
2220